| 08.09.2025 14:23 | VAL, VALT, AGL | Gfinity subsidiary collabs for sovereign AI in corporate training | Alliance |
| 04.09.2025 07:55 | VAL, VALT, AGL | Anglo American nets ZAR44 billion after selling entire Valterra stake | Alliance |
| 03.09.2025 17:22 | VAL, VALT, AGL | Anglo American intends to sell entire stake in Valterra via bookbuild | Alliance |
| 01.09.2025 14:02 | VAL | ValiRx's Cytolytix gets EU patent allowance for nanoparticles | Alliance |
| 01.09.2025 12:28 | VAL, VALT, BMS | UK dividends calendar - next 7 days | Alliance |
| 01.09.2025 10:35 | MKA, VAL, GLR | AIM WINNERS & LOSERS: Mkango interim loss widens on China restrictions | Alliance |
| 01.09.2025 07:00 | VAL | Cytolytix Commercial update | RNS |
| 26.08.2025 14:23 | VAL | ValiRx establishes new subsidiary for prostate cancer assets | Alliance |
| 26.08.2025 07:00 | VAL | Commercial update | RNS |
| 14.08.2025 15:29 | XPS, WPM, VAL | UK dividends calendar - next 7 days | Alliance |
| 07.08.2025 10:51 | VAL | ValiRx Awarded Grant from Open University | RNS |
| 05.08.2025 09:53 | VAL | Update on Evaluation Agreement with Stingray Bio | RNS |
| 04.08.2025 14:25 | VAL | ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing deal | Alliance |
| 04.08.2025 07:00 | VAL | Licensing Agreement with Dominion Biotech Ltd | RNS |
| 29.07.2025 10:05 | IGR, RSG, BHP | LONDON BROKER RATINGS: LBBW cuts BT; Shore cuts Paragon Banking | Alliance |
| 29.07.2025 07:00 | VAL | Collaboration Agreement with Voxcell BioInnovation | RNS |
| 28.07.2025 08:09 | VAL, VALT | Valterra Platinum interim profit dives on demerger costs, low output | Alliance |
| 24.07.2025 09:57 | BHP, VAL, VALT | LONDON BROKER RATINGS: Kepler starts Bellway with 'buy', Vistry 'hold' | Alliance |
| 21.07.2025 16:43 | VAL, VALT, SAG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 21.07.2025 09:33 | BHP, VAL, VALT | LONDON BROKER RATINGS: Stifel cuts Weir Group; BofA raises Pennon | Alliance |
| 18.07.2025 08:45 | AGL, AAL, VAL | Valterra Platinum expects interim earnings to tumble on demerger costs | Alliance |
| 17.07.2025 13:23 | VAL, VALT | IN BRIEF: Valterra Platinum beefs up board with two appointments | Alliance |
| 08.07.2025 09:42 | RIO, GLEN, ANTO | LONDON BROKER RATINGS: BofA raises Persimmon; Citi cuts Man Group | Alliance |
| 30.06.2025 15:48 | VAL | Result of AGM | RNS |
| 20.06.2025 10:41 | VAL | ValiRx signs licence with Ambrose worth GBP16 million plus royalties | Alliance |
| 20.06.2025 07:00 | VAL | Ambrose Exercise Option on VAL401 | RNS |
| 18.06.2025 12:10 | VAL, VALT, AGL | Anglo American trims leadership as business simplification advances | Alliance |
| 09.06.2025 10:57 | VAL | ValiRx Investor Webinar | RNS |
| 06.06.2025 10:54 | VAL | Holding(s) in Company | RNS |
| 06.06.2025 07:00 | VAL | Final Results & Notice of AGM | RNS |
| 03.06.2025 15:31 | VAL | ValiRx subsidiary enters evaluation agreement with Omios Biologics | Alliance |
| 03.06.2025 07:00 | VAL | New Evaluation and Material Transfer Agreement | RNS |
| 02.06.2025 11:14 | VAL, VALT, AGL | Anglo American completes demerger as Valterra Platinum debuts on LSE | Alliance |
| 02.06.2025 10:48 | AGL, AAL, VAL | Indivior to leave London Stock Exchange in July to focus on US listing | Alliance |
| 20.05.2025 13:25 | VAL | Holding(s) in Company | RNS |
| 12.05.2025 21:40 | VAL | IN BRIEF: ValiRx extends agreement with Dominion Biotech | Alliance |
| 12.05.2025 07:00 | VAL | Inaphaea Deal Extension With Dominion | RNS |
| 30.04.2025 07:00 | VAL | Commercial Update | RNS |
| 04.04.2025 18:29 | VAL, MET1, CORD | TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract | Alliance |
| 03.04.2025 07:00 | VAL | Termination of Letter of Intent with TheoremRx | RNS |
| 27.03.2025 07:00 | VAL | Directorate Changes and new Advisory Board | RNS |
| 21.03.2025 11:07 | VAL | Director Disclosure Update | RNS |
| 24.02.2025 16:20 | VAL | ValiRx shares fall as ends collaboration with Imperial College London | Alliance |
| 24.02.2025 07:00 | VAL | Conclusion of Evaluation Project | RNS |
| 03.02.2025 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
| 30.01.2025 07:00 | VAL | Extension of Evaluation Agreement | RNS |
| 29.01.2025 07:00 | VAL | New Evaluation and Option Agreement | RNS |
| 15.01.2025 12:47 | PEEL, VAL | Holding(s) in Company | RNS |
| 15.01.2025 11:29 | VAL | Holding(s) in Company | RNS |
| 14.01.2025 07:00 | VAL | Holding(s) in Company | RNS |
| 09.01.2025 11:37 | VAL | Holding(s) in Company | RNS |
| 09.01.2025 11:14 | VAL | Holding(s) in Company | RNS |
| 08.01.2025 07:00 | VAL | Holding(s) in Company | RNS |
| 02.01.2025 11:45 | VAL | Holding(s) in Company | RNS |
| 31.12.2024 13:06 | VAL | Holding(s) in Company | RNS |
| 31.12.2024 10:58 | SAR, VAL, ROSE | AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank | Alliance |
| 31.12.2024 10:58 | VAL | ValiRx extends TheoremRx exclusivity period to final May 31 deadline | Alliance |
| 31.12.2024 08:39 | VAL | Update on proposed sub-license of VAL201 | RNS |
| 30.12.2024 13:30 | VAL | Result of GM, Issue of Equity, Warrants and TVR | RNS |
| 20.12.2024 07:00 | VAL | ValiRx launches new interactive investor website | Reach |
| 22.11.2024 07:00 | VAL | Inaphaea award of HEIF Funding and PhD sponsorship | RNS |
| 20.11.2024 18:09 | VAL | IN BRIEF: ValiRx extends Ambrose Healthcare exclusivity agreement | Alliance |
| 20.11.2024 07:00 | VAL | Update on proposed sub-license of VAL401 | RNS |
| 19.11.2024 11:39 | VAL | ValiRX adds to streak of deals with cancer cell test materials win | Alliance |
| 19.11.2024 10:39 | WBI, VAL | AIM WINNERS & LOSERS: Woodbois subscription raises over GBP1 million | Alliance |
| 18.11.2024 12:21 | VAL | IN BRIEF: ValiRx notes subsidiary's shipment of patient derived cells | Alliance |
| 30.10.2024 07:00 | VAL | Update on proposed sub-license of VAL201 | RNS |
| 18.10.2024 07:00 | VAL | Directorate Change | RNS |
| 14.10.2024 07:00 | VAL | Investor Webinar | RNS |
| 07.10.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
| 27.09.2024 13:56 | ROQ, KDNC, VAL | EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart | Alliance |
| 27.09.2024 07:00 | VAL | Half-year Report | RNS |
| 24.09.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
| 18.09.2024 07:00 | VAL | Inaphaea Evaluation and Commercial Use Agreement | RNS |
| 16.09.2024 07:00 | VAL | Inaphaea Co-Marketing Agreement | RNS |
